MDR1 P-glycoprotein Reduces Influx of Substrates without Affecting Membrane Potential

This publication has 45 references indexed in Scilit:

• What is the Precise Role of Human MDR 1 Protein in Chemotherapeutic Drug Resistance
  Current Pharmaceutical Design, 2000
• Metal Complexes for Therapy and Diagnosis of Drug Resistance
  Chemical Reviews, 1999
• Stimulation of P‐glycoprotein‐mediated drug transport by prazosin and progesterone
  European Journal of Biochemistry, 1999
• Negative Regulation of MDR1 Promoter Activity in MCF-7, but Not in Multidrug Resistant MCF-7/Adr, Cells by Cross-Coupled NF-κB/p65 and c-Fos Transcription Factors and Their Interaction with the CAAT Region
  Biochemistry, 1999
• Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells
  American Journal of Physiology-Cell Physiology, 1997
• Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
  Physiological Reviews, 1997
• MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine
  Cell, 1996
• Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy
  Magnetic Resonance Imaging, 1994
• Membrane potential determination in large unilamellar vesicles with hexakis(2-methoxyisobutylisonitrile)technetium(I)
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1993
• Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.
  Circulation, 1990